12 infant deaths reported in clinical trials for FDA-endorsed RSV drug
The following is from The Vaccine Reaction. On June 8, 2023, the U.S. Food and Drug Administration’s (FDA) Antimicrobial Drugs Advisory Committee (AMDAC) voted unanimously (21-0) in favor of AstraZeneca and Sanofi’s new nirsevimab (Beyfortus) monoclonal antibody drug believed to […]
12 infant deaths reported in clinical trials for FDA-endorsed RSV drug Read More »
